Skip to main content
ASTERDM · Health Care · 2026-08-21

Aster DM Healthcare Ltd

5.2★ FairSolid +5.8Stage 2 · wk 19In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹761.6
-0.54% today
₹66,382 Cr · Large cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India.

Visit company website →
P/E (TTM)
116.5
Forward 38.7
Earnings Growth (YoY)
+71.5%
Revenue +18.2%
ROE
+10.1%
Profit margin +8.4%
Dividend Yield
0.53%
P/B 8.3
vs 52W High
-12.4%
₹535.6 lo₹869.7 hi
12.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 19
1w13w26w
Week 19 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
9.8%
200 DMA: ₹693.4 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
1.51x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
MA20 flat · +0.5% vs MA50 +3.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #32 of 84 Stage 2 stocks in Health Care by RS.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #3 of 15 Stage 2 stocks in this industry. Top tier.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 58w
S2 27w
S2 34w
S2 19w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 58w → S3 5w → S2 27w → S3 9w → S2 34w → S3 6w → S4 5w → S1 4w → S2 19w current
Total tracked: 168 weeks across 9 stage runs.
1M
-2.9%
3M
+0.7%
6M
+23.2%
YTD
+25.2%
1Y
+25.0%
Scan Membership
Breakout Watch
Latest: 2026-04-10
3 appearances in last 60 days. First seen: 2024-08-16.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 19 · Vol x
2026-08-20S2
Wk 19 · Vol x
2026-08-19S2
Wk 18 · Vol x
2026-08-18S2
Wk 18 · Vol x
2026-08-17S2
Wk 18 · Vol x
2026-08-14S2
Wk 18 · Vol x
2026-08-13S2
Wk 18 · Vol x
2026-08-12S2
Wk 17 · Vol x
2026-08-11S2
Wk 17 · Vol x
2026-08-10S2
Wk 17 · Vol x
2026-08-07S2
Wk 17 · Vol x
2026-08-06S2
Wk 17 · Vol x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹804.9
200 DMA
₹693.4
52W High
₹869.7
52W Low
₹535.6
5D Low
₹761.6
Resistance levels (recent highs)
20d High
₹869.7
60d High
₹869.7
120d High
₹869.7
250d High
₹869.7
Next resistance
+14.2%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.